Paper39289337
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression.
Amengual J and 11 others. Cell Death Dis, 2024. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression. Papers, record 39289337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39289337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis | Major topic |
| Cellular Senescence | Major topic |
| Iron Chelating Agents | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Male | |
| Disease Progression | |
| Iron | |
| Hepatocytes | |
| Mice, Inbred C57BL | |
| Carbon Tetrachloride | |
| Deferiprone | |
| Reactive Oxygen Species | |
| Disease Models, Animal |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33128017 | Molecular and cellular mechanisms of liver fibrosis and its regression. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33128017 | PubMed |
| 2 | 30111642 | TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/30111642 | PubMed |
| 3 | 37438332 | Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37438332 | PubMed |
| 4 | 37463530 | Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma. | Redox Biol | 2023 | https://conductscience.org/library/papers/37463530 | PubMed |
| 5 | 36389734 | IL-2 availability regulates the tissue specific phenotype of murine intra-hepatic Tregs. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389734 | PubMed |
| 6 | 35974106 | A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. | Nat Commun | 2022 | https://conductscience.org/library/papers/35974106 | PubMed |
| 7 | 23104886 | STAR: ultrafast universal RNA-seq aligner. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23104886 | PubMed |
| 8 | 31590120 | New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases. | Curr Opin Pharmacol | 2019 | https://conductscience.org/library/papers/31590120 | PubMed |
| 9 | 29158192 | Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29158192 | PubMed |
| 10 | 27168353 | Deferoxamine alleviates liver fibrosis induced by CCl4 in rats. | Clin Exp Pharmacol Physiol | 2016 | https://conductscience.org/library/papers/27168353 | PubMed |
| 11 | 33982327 | Liver Sinusoidal Endothelial Cells Suppress Bone Morphogenetic Protein 2 Production in Response to TGFβ Pathway Activation. | Hepatology | 2021 | https://conductscience.org/library/papers/33982327 | PubMed |
| 12 | 26147250 | MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/26147250 | PubMed |
| 13 | 27339419 | Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue. | Arch Toxicol | 2016 | https://conductscience.org/library/papers/27339419 | PubMed |
| 14 | 35731891 | Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35731891 | PubMed |
| 15 | 34089528 | Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. | Hepatology | 2021 | https://conductscience.org/library/papers/34089528 | PubMed |
| 16 | 30774269 | Iron and liver fibrosis: Mechanistic and clinical aspects. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/30774269 | PubMed |
| 17 | 34923653 | Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. | Hepatology | 2022 | https://conductscience.org/library/papers/34923653 | PubMed |
| 18 | 18724938 | Senescence of activated stellate cells limits liver fibrosis. | Cell | 2008 | https://conductscience.org/library/papers/18724938 | PubMed |
| 19 | 38022905 | Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches. | J Pharm Pharm Sci | 2023 | https://conductscience.org/library/papers/38022905 | PubMed |
| 20 | 33764485 | Cellular Senescence in Liver Disease and Regeneration. | Semin Liver Dis | 2021 | https://conductscience.org/library/papers/33764485 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42924596 | Mechanisms and therapeutic implications of ferritinophagy in fibrotic diseases (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42924596 | PubMed |
| 42856971 | Context-dependent duality of senescent cells in liver fibrosis. | Liver Res | 2026 | https://conductscience.org/library/papers/42856971 | PubMed |
| 42783816 | Ferroptosis and Ferro-Aging in Obesity: Bibliometric Mapping, Shared Mechanisms, and Translational Perspectives. | Metabolites | 2026 | https://conductscience.org/library/papers/42783816 | PubMed |
| 42717163 | Copper and iron engage distinct metabolic programs for cellular survival. | Geroscience | 2026 | https://conductscience.org/library/papers/42717163 | PubMed |
| 42704398 | Deferiprone Modulates Ferroptosis to Protect Macrophages and Liver during Neospora caninum Infection. | Acta Parasitol | 2026 | https://conductscience.org/library/papers/42704398 | PubMed |
| 42649158 | ACSS2-KAT5 complex-driven histone crotonylation orchestrates a pro-inflammatory program to promote the transition from MASLD to MASH. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649158 | PubMed |
| 42395638 | From bench to bedside: Molecular mechanisms, diagnostic tools, and therapeutic strategies in liver fibrosis. | Liver Res | 2026 | https://conductscience.org/library/papers/42395638 | PubMed |
| 42318359 | The SIRT1-p53 axis drives a ferro-aging-like program and aggravates trophoblast dysfunction in preeclampsia. | Front Aging | 2026 | https://conductscience.org/library/papers/42318359 | PubMed |
| 42182421 | Reduction in Hepatic Phosphatidylcholine Biosynthesis Promotes MASH Through Copper Deficiency. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182421 | PubMed |
| 41596074 | Targeting Aging and Diseases Associated with Ferroptosis and Senescence Through Modulation of Iron, Oxidative Stress and Lipid Peroxidation. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41596074 | PubMed |
| 41304484 | Polychlorinated Biphenyl 138 Induces Toxicant-Associated Steatohepatitis via Hepatic Iron Overload and Adipose Inflammation. | Toxics | 2025 | https://conductscience.org/library/papers/41304484 | PubMed |
| 41057934 | Reversing coma by senolytics and stem cells: the future is now. | J Transl Med | 2025 | https://conductscience.org/library/papers/41057934 | PubMed |
| 41049034 | Deciphering the Role of Oroxylin A in Liver Fibrosis. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41049034 | PubMed |
| 40691373 | Astragalin promotes HSCs ferroptosis through NCOA4 mediated ferritinophagy to alleviate liver fibrosis in zebrafish and mice. | Commun Biol | 2025 | https://conductscience.org/library/papers/40691373 | PubMed |
| 39578455 | Emerging insights in senescence: pathways from preclinical models to therapeutic innovations. | NPJ Aging | 2024 | https://conductscience.org/library/papers/39578455 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ASPRV1 | 151516 | PubTator's text mining | https://conductscience.org/library/genes/151516 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE265969 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39289337
GET https://conductscience.org/api/papers/v1/39289337/references?page=2